Full text

Turn on search term navigation

Copyright John Wiley & Sons, Inc. 2022

Abstract

Organ fabrication as the solution to renewable donor demands requires the ability to spatially deposit viable cells into biologically relevant constructs; necessitating reliable and effective cell deposition through bioprinting and the subsequent ability to mature. However, effective bioink development demands advances in both printability and control of cellular response. Effective bioinks are designed to retain shape fidelity, influence cellular behavior, having bioactive morphologies stiffness and highly hydrated environment. Hybrid hydrogels are promising candidates as they reduce the need to re‐engineer materials for tissue‐specific properties, with each component offering beneficial properties. Herein, a multicomponent bioink is developed whereby gelatin methacrylate (GelMA) and fluorenylmethoxycarbonyprotected self‐assembling peptides (Fmoc‐SAPs) undergo coassembly to yield a tuneable bioink. This study shows that the reported fibronectin‐inspired fmoc‐SAPs present cell attachment epitopes RGD and PHSRN in the form of bioactive nanofibers; and that the GelMA enables superior printability, stability in media, and controlled mechanical properties. Importantly, when in the hybrid format, no disruption to either the methacrylate crosslinking of GelMA, or self‐assembled peptide fibril formation is observed. Finally, studies with primary myoblasts show over 98% viability at 72 h and differentiation into fused myotubes at one and two weeks demonstrate the utility of the material as a functional bioink for muscle engineering.

Details

Title
Hybrid Self‐Assembling Peptide/Gelatin Methacrylate (GelMA) Bioink Blend for Improved Bioprintability and Primary Myoblast Response
Author
Boyd-Moss, Mitchell 1 ; Firipis, Kate 2 ; Quigley, Anita 2 ; Rifai, Aaqil 1 ; Cichocki, Artur 2 ; Whitty, Sarah 2 ; Ngan, Catherine 3 ; Dekiwadia, Chaitali 4 ; Long, Benjamin 5 ; Nisbet, David R. 6   VIAFID ORCID Logo  ; Kapsa, Robert 2 ; Williams, Richard J. 1 

 iMPACT, School of Medicine, Deakin University, Waurn Ponds, VIC, Australia 
 School of Engineering, RMIT University, Melbourne, VIC, Australia 
 BioFab3D, Aikenhead Centre for Medical Discovery, St Vincent's Hospital Melbourne, Fitzroy, Australia 
 RMIT Microscopy and MicroAnalysis Facility, RMIT University, Melbourne, VIC, Australia 
 Faculty of Science and Technology, Federation University, Mt. Helen, VIC, Australia 
 Research School of Engineering, Australian National University, Canberra, ACT, Australia 
Section
Research Articles
Publication year
2022
Publication date
Feb 1, 2022
Publisher
John Wiley & Sons, Inc.
ISSN
26999307
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3091656630
Copyright
Copyright John Wiley & Sons, Inc. 2022